Neurologist care in Parkinson disease: A utilization, outcomes, and survival study

Neurology

Volumn 77, Issue 9, 2011, Pages 851-857

  Willis, A W ^a   Schootman, M ^a   Evanoff, B A ^a   Perlmutter, J S ^a,b   Racette, B A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CAUSE OF DEATH; COMORBIDITY; FEMALE; GENERAL PRACTITIONER; HEALTH CARE UTILIZATION; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT CARE; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUALITY OF LIFE; RACE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; UNITED STATES; COHORT ANALYSIS; COMPARATIVE STUDY; MANPOWER; METHODOLOGY; MORTALITY; NEUROLOGY; PHYSICIAN ATTITUDE; TREATMENT OUTCOME; UTILIZATION REVIEW;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; MALE; MEDICARE PART A; MEDICARE PART B; NEUROLOGY; PARKINSON DISEASE; PATIENT CARE; PHYSICIAN'S ROLE; PHYSICIANS, PRIMARY CARE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 80055081758     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31822c9123     Document Type: Article

References (29)

1. Coeytaux RR, Linville JC. Chronic daily headache in a primary care population: prevalence and headache impact test scores. Headache 2007;47:7-12. (Pubitemid 46096051)
2. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123:665-676. (Pubitemid 30162716)
3. Maarsingh OR, Dros J, Schellevis FG, van Weert HC, Bindels PJ, Horst HE. Dizziness reported by elderly patients in family practice: prevalence, incidence, and clinical characteristics. BMC Fam Pract 2010;11:2.
4. Flanagan E, Walsh C, Tubridy N. 'Neurophobia': attitudes of medical students and doctors in Ireland to neurological teaching. Eur J Neurol 2007;14:1109-1112. (Pubitemid 47459739)
5. Jozefowicz RF. Neurophobia: the fear of neurology among medical students. Arch Neurol 1994;51:328-329. (Pubitemid 24110514)
6. Ridsdale L, Massey R, Clark L. Preventing neurophobia in medical students, and so future doctors. Pract Neurol 2007;7:116-123. (Pubitemid 46578852)
7. Zinchuk AV, Flanagan EP, Tubridy NJ, Miller WA, Mc- Cullough LD. Attitudes of US medical trainees towards neurology education: "neurophobia": a global issue. BMC Med Educ 2010;10:49.
8. Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 2002;72:721-725. (Pubitemid 34557012)
9. Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women: the Northeast Hip Fracture Study Group. N Engl J Med 1991;324:1326-1331.
10. Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology 2010;34:143-151.
11. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47:1245-1251. (Pubitemid 24361532)
12. Mukherjee D, Kosztowski T, Zaidi HA, et al. Disparities in access to pediatric neurooncological surgery in the United States. Pediatrics 2009;124:e688-e696.
13. Hayanga AJ, Waljee AK, Kaiser HE, Chang DC, Morris AM. Racial clustering and access to colorectal surgeons, gastroenterologists, and radiation oncologists by African Americans and Asian Americans in the United States: a county-level data analysis. Arch Surg 2009;144:532-535.
14. Schootman M, Lian M, Deshpande AD, et al. Temporal trends in area socioeconomic disparities in breast-cancer incidence and mortality, 1988-2005. Breast Cancer Res Treat 2010;122:533-543.
15. Schootman M, Lian M, Deshpande AD, et al. Temporal trends in area socioeconomic disparities in breast-cancer incidence and mortality, 1988-2005. Breast Cancer Res Treat 2010;122:533-543.
16. Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA 2009;302:1573-1579.
17. US Census Bureau. Labor statistics. 2011. www.bls.gov. Accessed in August 2011.
18. Shi N, Foley K, Lenhart G, Badamgarav E. Direct healthcare costs of hip, vertebral, and non-hip, non-vertebral fractures. Bone 2009;45:1084-1090.
19. Fahn S. Does levodopa slow or hasten the rate of progression of Parkinson's disease? J Neurol 2005;252(suppl 4): IV37-IV42. (Pubitemid 41437719)
20. Hauser RA, Auinger P, Oakes D. Levodopa response in early Parkinson's disease. Mov Disord 2009;24:2328-2336.
21. Mizuno Y, Abe T, Hasegawa K, et al. Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Mov Disord 2007;22:1860-1865. (Pubitemid 350134197)
22. Pinter MM, Pogarell O, Oertel WH. Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study. J Neurol Neurosurg Psychiatry 1999;66:436-441. (Pubitemid 29145676)
23. Rinne UK, Larsen JP, Siden A, Worm-Petersen J. Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations: Nomecomt Study Group. Neurology 1998;51:1309-1314. (Pubitemid 28520549)
24. Roberts JW, Cora-Locatelli G, Bravi D, Amantea MA, Mouradian MM, Chase TN. Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients. Neurology 1993;43:2685-2688. (Pubitemid 24004569)
25. Waters CH, Sethi KD, Hauser RA, Molho E, Bertoni JM. Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study. Mov Disord 2004;19:426-432. (Pubitemid 38559645)
26. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study. Arch Neurol 2005; 62:241-248.
27. Hemming JP, Gruber-Baldini AL, Anderson KE, et al. Racial and socioeconomic disparities in Parkinsonism. Arch Neurol 2010;68:498-503.
28. Sethi KD, Meador KJ, Loring D, Meador MP. Neuroepidemiology of Parkinson's disease: analysis of mortality data for the U.S.A. and Georgia. Int J Neurosci 1989;46:87-92.
29. Kurtzke JF, Goldberg ID. Parkinsonism death rates by race, sex, and geography. Neurology 1988;38:1558-1561.